Previous 10 | Next 10 |
DaVita ( NYSE: DVA ) is scheduled to announce Q3 earnings results on Friday, October 28th, before market open. The consensus EPS Estimate is $1.77 (-25.0% Y/Y) and the consensus Revenue Estimate is $2.98B (+1.4% Y/Y). Over the last 2 years, DVA has beaten EPS estimat...
Summary Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breaking out of one of its most important short-term resistance. In this tec...
Summary Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages. Other healthcare industries don’t look attractive. Focus on a biotech ETF: GNOM (and why I don’t like it). ...
DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call PR Newswire DENVER , Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, Octob...
The DaVita Giving Foundation Provides $1.4 Million Grant Toward Addressing Food Insecurity PR Newswire Grant to enable nonprofit organizations in the Food Is Medicine Coalition to expand services for medically-tailored meals for individuals with chronic medical conditi...
Summary The Health Care sector has been a source of relative safety during this tumultuous September. While some large-caps in the space are catching bids, one smaller health care services and facilities company is sharply lower in 2022. Earnings are expected to improve, but t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities are a...
Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...
DaVita Announces Adam H. Schechter to Join its Board of Directors PR Newswire DENVER , Sept. 13, 2022 /PRNewswire/ -- DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter , to join the Boa...
Summary Glenview Capital Management’s 13F portfolio value decreased from $4.94B to $4B this quarter. The number of positions decreased from 60 to 55. They increased Cigna, Aptiv plc, and Change Healthcare while dropping Bausch Health, Meritor, and AmerisourceBergen. The...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...